HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 10, 2015, Pages 1783-1789

  Verneris, Michael R ^a   Lee, Stephanie J ^b   Ahn, Kwang Woo ^c   Wang, Hai Lin ^c   Battiwalla, Minoo ^d   Inamoto, Yoshihiro ^b   Fernandez Vina, Marcelo A ^e   Gajewski, James ^f   Pidala, Joseph ^g   Munker, Reinhold ^h   Aljurf, Mahmoud ⁱ   Saber, Wael ^c   Spellman, Stephen ^j   Koreth, John ^k  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e STANFORD UNIVERSITY   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

^h Louisiana State University School of Medicine Shreveport   (United States)

ⁱ KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^j CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^k DANA FARBER CANCER INSTITUTE   (United States)

more..

Author keywords

Bone marrow transplantation; Hematologic malignancies; Leukemia; Pediatric oncology

Indexed keywords

CYCLOSPORIN A; HLA DRB1 ANTIGEN; TACROLIMUS; HLA ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLELE; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; REDUCED INTENSITY CONDITIONING; RELAPSE; T CELL DEPLETION; UNRELATED DONORS; WHOLE BODY RADIATION; ADOLESCENT; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; KAPLAN MEIER METHOD; LEUKEMIA; LIVING DONOR; MYELODYSPLASTIC SYNDROMES; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA; LIVING DONORS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941318174     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.05.028     Document Type: Article

References (26)

1. Foeken L.M., Green A., Hurley C.K., et al. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010, 45:811-818.
2. Petz L.D., Spellman S.S., Gragert L. The underutilization of cord blood transplantation: extent of the problem, causes, and methods improvement. Cord Blood: Biology, Transplantation, Banking, and Regulation 2011, 557-584. AABB Press, Bethesda, MD. H.E. Broxmeyer (Ed.).
3. Morishima Y., Sasazuki T., Inoko H., et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002, 99:4200-4206.
4. Sasazuki T., Juji T., Morishima Y., et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 1998, 339:1177-1185.
5. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
6. Loiseau P., Busson M., Balere M.L., et al. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 2007, 13:965-974.
7. Petersdorf E.W., Gooley T., Malkki M., Horowitz M. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. Tissue Antigens 2007, 69(Suppl 1):25-30.
8. Shaw B.E., Gooley T.A., Malkki M., et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 2007, 110:4560-4566.
9. Eapen M., Rocha V., Sanz G., et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010, 11:653-660.
10. Ho V.T., Kim H.T., Liney D., et al. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant 2006, 37:845-850.
11. Woolfrey A., Klein J.P., Haagenson M., et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2011, 17:885-892.
12. Nakamae H., Storer B.E., Storb R., et al. Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial. Biol Blood Marrow Transplant 2010, 16:384-394.
13. Lauterbach N., Crivello P., Wieten L., et al. Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain. Mol Immunol 2014, 59:19-29.
14. Fleischhauer K., Fernandez-Vina M.A., Wang T., et al. Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1. Bone Marrow Transplant 2014, 49:1176-1183.
15. Farag S.S., Bacigalupo A., Eapen M., et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch registry. Biol Blood Marrow Transplant 2006, 12:876-884.
16. Spellman S., Setterholm M., Maiers M., et al. Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry. Biol Blood Marrow Transplant 2008, 14:37-44.
17. Marsh S.G., Albert E.D., Bodmer W.F., et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010, 75:291-455.
18. Hurley C.K., Woolfrey A., Wang T., et al. The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors. Blood 2013, 121:4800-4806.
19. Fernandez-Vina M.A., Wang T., Lee S.J., et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood 2014, 123:1270-1278.
20. Fleischhauer K., Shaw B.E., Gooley T., et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol 2012, 13:366-374.
21. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104:1923-1930.
22. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974, 18:295-304.
23. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
24. Pidala J., Lee S.J., Ahn K.W., et al. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood 2014, 124:2596-2606.
25. Weisdorf D.J., Nelson G., Lee S.J., et al. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. Biol Blood Marrow Transplant 2009, 15:1475-1478.
26. Ringden O., Pavletic S.Z., Anasetti C., et al. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 2009, 113:3110-3118.